| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/15/1994 | EP0601623A1 Novel, 2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof |
| 06/15/1994 | EP0601616A1 Iodinated aroyloxy carboxamides and contrast agents containing them |
| 06/15/1994 | EP0601573A1 Alpha-phosphonocarboxylate squalene synthetase inhibitors and method |
| 06/15/1994 | EP0601547A1 Crystalline salts of optically active aminocoumaran derivatives, their production and use |
| 06/15/1994 | EP0601508A2 Liquid-suspension controlled-release pharmaceutical composition |
| 06/15/1994 | EP0601486A1 Cis-epoxide derivatives useful as irreversible HIV protease inhibitors and process and intermediates for their preparation |
| 06/15/1994 | EP0601417A2 Physiologically compatible and degradable polymer-based carbohydrate receptor blockers, a method for their preparation and their use |
| 06/15/1994 | EP0601386A1 Sulphonamides |
| 06/15/1994 | EP0601385A1 Disubstituted benzoic acid derivatives |
| 06/15/1994 | EP0601345A1 Medicament containing an imidazol-1-yl compound |
| 06/15/1994 | EP0601249A1 Benzocycloheptene derivative and process for preparation thereof |
| 06/15/1994 | EP0601197A1 5-aminoquinolonecarboxylic acid derivative and antibacterial containing the same as active ingredient |
| 06/15/1994 | EP0601191A1 Novel tetracyclic compound |
| 06/15/1994 | EP0601183A1 Anti-hiv drug |
| 06/15/1994 | EP0601164A1 Methods for treating viral infections |
| 06/15/1994 | EP0601088A1 Use of n-acetyl-l-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy. |
| 06/15/1994 | EP0601058A1 Transdermal formulations for administering prazosin |
| 06/15/1994 | EP0601039A1 Angiotensin ii receptor blocking imidazolinone derivatives |
| 06/15/1994 | EP0601002A1 Bicyclic sulphones, process for producing the same and medicaments containing the same. |
| 06/15/1994 | EP0600973A1 A method for treatment of metabolic disorders and metabolism |
| 06/15/1994 | EP0600955A1 5-ht4 receptor antagonists |
| 06/15/1994 | EP0600950A1 Amide tetrazole acat inhibitors. |
| 06/15/1994 | EP0600949A1 New 3,5-di-tert.butyl-4-hydroxyphenyl derivatives, methods of preparing them and drugs containing them. |
| 06/15/1994 | EP0600928A1 Dermatan sulphate possessing a thrombolytic activity, and pharmaceutical forms containing it |
| 06/15/1994 | EP0485381B1 Use of macrolactones as anti-allergy agents |
| 06/15/1994 | EP0469045B1 SYNTHETIC $i(PSEUDOMONAS) $i(AERUGINOSA) PILIN PEPTIDE AND RELATED VACCINES AND DIAGNOSTICS |
| 06/15/1994 | EP0458892B1 Use of chlormethiazole in the manufacture of a medicament for the prevention and/or treatment of neurodegeneration |
| 06/15/1994 | EP0396734B1 Pharmaceutical compositions for neuro protection containing arylcyclohexylamines |
| 06/15/1994 | EP0395757B1 Process for extracting physiologically active substance from pine seed shells and antiinfectant prepared mainly from the extract |
| 06/15/1994 | CN1087913A Rapamycin derivatives |
| 06/15/1994 | CN1087912A Rapamycin derivatives |
| 06/15/1994 | CN1087911A Rapamycin derivatives |
| 06/15/1994 | CN1087910A Process for preparing 5-substituted pyrrolo-Û2,3-DÙ pyrimidines |
| 06/15/1994 | CN1087907A Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis |
| 06/15/1994 | CN1087905A Preparation of derivative of taxane |
| 06/15/1994 | CN1087904A Carboxylic acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 06/15/1994 | CN1087902A Morpholine and thiomorpholine tachykinin receptor antagonists |
| 06/15/1994 | CN1087901A Novel pyridyl- and pyrimidylpiperazine derivatives |
| 06/15/1994 | CN1087900A Benzoylguanidine, preparation of same and application as pharmaceutical and pharmaceutical containing same |
| 06/15/1994 | CN1087899A 9-|(substituted glycyl) amido¨-6-demethyl-6-deoxytetracyclines |
| 06/15/1994 | CN1087816A Xanthate microwave drying process |
| 06/15/1994 | CN1087778A A method for preparing low free formaldehyde methylolhydantoins and compositions thereof |
| 06/15/1994 | CN1025033C Alkoxymethylidene epipodophyllotoxin glucosides |
| 06/15/1994 | CN1025032C Process for preparing 2-methoxymethyl-penem derivatives |
| 06/15/1994 | CN1025031C 2-oxo-3,8-diaza-spiro|4,5¨ decane derivatives, |
| 06/15/1994 | CN1025029C Prepn. for camptothecin arginine salt |
| 06/15/1994 | CN1025027C Prepn. of thiophen-2-oxatyl amidate |
| 06/15/1994 | CA2111302A1 3-(6-quinolylmethyl)-4h-imidazol-4-one derivatives, their preparation and their application in therapy |
| 06/14/1994 | US5321150 Treating susceptible neoplasms in mammals |
| 06/14/1994 | US5321145 Process of producing phosphatidylcholine derivatives |
| 06/14/1994 | US5321141 Reacting an isothiazole with an a,b-unsaturated ketone or aldehyde |
| 06/14/1994 | US5321140 Pyridinecarboxaldehyde D-ring intermediates useful for the synthesis of camptothecin and camptothecin analogs |
| 06/14/1994 | US5321137 Process for the preparation of imidazopyridines |
| 06/14/1994 | US5321133 Sulphated polysaccharides, anticoagulant agent and anticomplementary agent obtained from brown algae fucuses and method of obtaining same |
| 06/14/1994 | US5321128 Vision defects |
| 06/14/1994 | US5321046 Hypocholesterolemic unsymmetrical dithiol ketals |
| 06/14/1994 | US5321045 PAF-induced bronchial obstructions |
| 06/14/1994 | US5321044 15,16-seco-19-nor progestins |
| 06/14/1994 | US5321043 Method of combatting transplant rejection |
| 06/14/1994 | US5321042 Use of substituted tetrahydrothiophenes, some of which are known, as medicaments, new active substances and processes for their preparation |
| 06/14/1994 | US5321041 Diphenylpyrrolylfuran derivatives |
| 06/14/1994 | US5321039 Method of inducing a histamine agonist action on H2 receptors |
| 06/14/1994 | US5321037 Isoxazole derivatives for use as cerebro-active drugs and central muscle relaxants |
| 06/14/1994 | US5321034 Fibrinogen receptor antagonists |
| 06/14/1994 | US5321031 1,2-disubstituted ethyl amides as inhibitors of ACAT |
| 06/14/1994 | US5321030 Administering for treatment or prevention |
| 06/14/1994 | US5321027 Analgesic |
| 06/14/1994 | US5321026 Phenothiazine derivatives, their preparation and pharmaceutical compositions containing them |
| 06/14/1994 | US5321025 Benzothiaziny derivatives |
| 06/14/1994 | US5321024 Antiviral pharmaceutical composition for treating lymphocytes |
| 06/14/1994 | US5321023 Pyridoindolobenzodiazepines and derivatives as antipsychotics |
| 06/14/1994 | US5321022 Mixture of emedastine (a diazepiny/benzimidazole derivative) and aliphatic mono- and di-alkyl esters |
| 06/14/1994 | US5321019 Bile acid sulfurated derivatives |
| 06/14/1994 | US5321018 Use of 1α-hydroxylated-19-nor-vitamin D compounds to treat psoriasis |
| 06/14/1994 | US5321017 Composition comprising fluriprofen and effectively non-antibacterial tetracycline to reduce bone loss |
| 06/14/1994 | US5321013 Pharmaceutical compositions in the form of stable sucralfate suspensions free of suspending agents |
| 06/14/1994 | US5321012 Using nontoxic material such as dextromethorphan, trifluoro-perazine, dextrorphan |
| 06/14/1994 | US5320853 Controlled release formulation for pharmaceutical compounds |
| 06/14/1994 | US5320850 Transdermal delivery of the gestogen ST-1435 and devices therefor |
| 06/14/1994 | US5320849 Anti-virus agent |
| 06/14/1994 | US5320842 Anti-microbial |
| 06/14/1994 | US5320841 Vision disorders, ophthalmology |
| 06/14/1994 | US5320839 Topical ophthalmic compositions comprising 4-(3-substituted amino-2-hydroxypropoxy)-1,2,5-thiadiazoles and methods for their use |
| 06/14/1994 | US5320838 Protectant for irritated skin containing polyethyleneglycols, polyvinylether salt anhydride and polyvinylpyrrolidone |
| 06/14/1994 | US5320601 Method for treatment of cholelithiasis and chronic hepato- and cholecystopathies secondary to said disease |
| 06/14/1994 | CA1330198C Pharmaceutical composition containing propylene glycol and urea as active main components and use thereof |
| 06/12/1994 | CA2111181A1 Process for preparing 1-substituted-6-fluoro-4-oxo-7- (1-piperazinyl)-1,4-dihydroquinoline-3-carboxylic acid, a novel intermediate useful in said process, and a process for preparing said intermediate |
| 06/12/1994 | CA2111152A1 New 4-methyl-1, 3-oxazole derivatives, process for their preparation and pharmaceutical compositions containing them |
| 06/12/1994 | CA2111129A1 Physiologically tolerated and physiologically degradable polymer-based carbohydrate receptor blocker, a process for its preparation and its use |
| 06/12/1994 | CA2110672A1 Spiro peperidines and holologs which promote release of growth hormone |
| 06/11/1994 | CA2111035A1 Carboxylic acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
| 06/11/1994 | CA2110944A1 Novel sulfonamides |
| 06/11/1994 | CA2110525A1 Antitumor compositions and methods of treatment |
| 06/11/1994 | CA2110524A1 Antitumor compositions and methods of treatment |
| 06/11/1994 | CA2085533A1 Danazol or pharmaceutical composition thereof for treatment of urinary incontinence |
| 06/10/1994 | CA2111033A1 Crystalline salts of optically active aminocoumaran derivatives, their production and use |
| 06/10/1994 | CA2110838A1 Hyrdroxyamidine derivatives |
| 06/10/1994 | CA2110633A1 Acylaminoacids |
| 06/10/1994 | CA2109771A1 .alpha.-phosphonocarboxylate squalene synthetase inhibitors |
| 06/09/1994 | WO1994012880A2 Rxr homodimer formation and bridged bicyclic aromatic compounds and their use in modulating gene expression |